Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 13 USDMF, 1 JDMF, 7 EU WC, 5 KDMF, 9 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers, 7 FDA Orange Book, 4 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 17 Thickeners and Stabilizers, 17 Solubilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 11 Film Formers & Plasticizers, 10 Lubricants & Glidants, 8 Parenteral, 6 Co-Processed Excipients, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 14 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/03/2025	Zhejiang Lepu Pharmaceutical	China	Zhejiang Lepu Pharmaceutical Co. , Ltd.	307MF10025	Pazopanib Hydrochloride	2025-02-07	2025-02-07	No. 29 Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, 318000, China

Pazopanib Hydrochloride

Pazopanib Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers

13 USDMF

1 JDMF

7 EU WC

5 KDMF

9 NDC API

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers

7 FDA Orange Book

4 Europe

2 Canada

12 Australia

2 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

5 DKSH

2 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 ACG Worldwide

2 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

1 Clariant

10 Corel Pharma Chem

3 DFE Pharma

9 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

15 Kerry

3 Kima Chemical

6 Lonza Capsugel

9 Microlex e.U

1 Nanjing Bold Chemical

2 Novo Excipients

3 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

11 Roquette

12 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

28 Fillers, Diluents & Binders

22 Controlled & Modified Release

17 Thickeners and Stabilizers

17 Solubilizers

15 Disintegrants & Superdisintegrants

13 Granulation

13 Direct Compression

11 Film Formers & Plasticizers

10 Lubricants & Glidants

8 Parenteral

6 Co-Processed Excipients

6 Rheology Modifiers

5 Empty Capsules

5 Coloring Agents

TABLET;ORAL - EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons